AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2021
Oct 13, 2021
32559_dirs_2021-10-12_b475607f-8ef7-436d-96df-9873ac4ecf9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2021-09-28
Reporting Person: Taylor Ann Elizabeth (Director)
More from Terns Pharmaceuticals, Inc.
Share Issue/Capital Change
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Share Issue/Capital Change
2026
May 5
Regulatory Filings
2026
May 5
Share Issue/Capital Change
2026
May 5
Share Issue/Capital Change
2026
May 5
Share Issue/Capital Change
2026
May 5
Share Issue/Capital Change
2026
May 5
M&A Activity
2026
May 5